🇺🇸 FDA
Patent

US 9539321

HMGB1-derived peptides enhance immune response to antigens

granted A61KA61K2039/55505A61K2039/55516

Quick answer

US patent 9539321 (HMGB1-derived peptides enhance immune response to antigens) held by The Regents of the University of California expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/55505, A61K2039/55516, A61K2039/55555, A61K2039/57